Home/Filings/4/0001613377-18-000006
4//SEC Filing

PASCALE ADAM 4

Accession 0001613377-18-000006

CIK 0000946644other

Filed

May 17, 8:00 PM ET

Accepted

May 18, 9:57 AM ET

Size

5.3 KB

Accession

0001613377-18-000006

Insider Transaction Report

Form 4
Period: 2018-05-16
Pascale Adam
Chief Accounting Officer
Transactions
  • Award

    Options to buy Common Stock

    2018-05-16+83,33483,334 total
    Exercise: $0.30From: 2018-05-16Exp: 2028-05-16Common Stock (83,334 underlying)
Footnotes (1)
  • [F1]This option is being issued to senior management in exchange for a voluntary 40% deferral in salary.

Issuer

HEMISPHERX BIOPHARMA INC

CIK 0000946644

Entity typeother

Related Parties

1
  • filerCIK 0001613377

Filing Metadata

Form type
4
Filed
May 17, 8:00 PM ET
Accepted
May 18, 9:57 AM ET
Size
5.3 KB